During the past decade, Excell Research, Inc. conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 41 clinical trials were completed, i.e. on average, 87.2% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 23 clinical trials were completed. i.e. 143.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Excell Research, Inc." #1 sponsor was "Sunovion" with 13 trials, followed by "Allergan" with 6 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 5 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 5 trials sponsored. Other sponsors include 41 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Excell Research, Inc." #1 collaborator was "APCER Life Sciences" with 1 trials as a collaborator, "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator, "Covance" with 1 trials as a collaborator, "Gedeon Richter Ltd." with 1 trials as a collaborator and "KCAS Bio" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Excell Research, Inc." are "Schizophrenia" (18 trials), "Depressive Disorder, Major" (10 trials), "Major Depressive Disorder" (8 trials), "Episodic Migraine" (3 trials) and "Adult Attention Deficit Hyperactivity Disorder" (2 trials). Many other conditions were trialed in "Excell Research, Inc." in a lesser frequency.

Most popular intervention types in "Excell Research, Inc." are "Drug" (79 trials), "Other" (4 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (42 trials), "Rapastinel" (5 trials), "Atogepant" (4 trials), "Lurasidone" (4 trials) and "placebo" (4 trials). Other intervention names were less common.

The vast majority of trials in "Excell Research, Inc." are 76 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Excell Research, Inc.". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 57 completed trials in Excell Research, Inc., undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Excell Research, Inc., 0 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".